70199-007 : Robinul 1 mg Oral Tablet


NDC: 70199-007
Labeler: Casper Pharma LLC
Product Type: Human Prescription Drug
Drug Name:  Robinul
Dosage Form: Oral Tablet
Application #: NDA012827
Rev. Date: 


NDC Package Codes:

  • 70199-007-30: 30 TABLET IN 1 CONTAINER (70199‑007‑30)
  • 70199-007-90: 90 TABLET IN 1 CONTAINER (70199‑007‑90)

Active Ingredients:

  • Glycopyrrolate

Dosage Strength:

  • 1 mg

Pharmaceutical Classes:

  • Anticholinergic [EPC]
  • Cholinergic Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 0641-6104 Robinul .2 mg/ml Intramuscular; Intravenous Injection by West-ward Pharmaceutical Corp.
  • 0641-6105 Robinul .2 mg/ml Intramuscular; Intravenous Injection by West-ward Pharmaceutical Corp.
  • 0641-6106 Robinul .2 mg/ml Intramuscular; Intravenous Injection by West-ward Pharmaceutical Corp.
  • 0641-6107 Robinul .2 mg/ml Intramuscular; Intravenous Injection by West-ward Pharmaceutical Corp.
  • 52584-107 Robinul .2 mg/ml Intramuscular; Intravenous Injection by General Injectables & Vaccines, Inc
  • 52584-155 Robinul .2 mg/ml Intramuscular; Intravenous Injection, Solution by General Injectables & Vaccines, Inc
  • 59630-200 Robinul 1 mg Oral Tablet by Shionogi Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70199-007 QR Code

< Prev: 70199-006Next: 70199-008 >

Related Discussions:

glycopyrrolate 1 mg uses
Can this medication be used for fluid in the stomach for a 99 year old? It was given to this patient. ## Hello, Izzy! Ho... 1 reply
glycopyrrolate 2 mg
...
Robinul Forte
Reason prescribed; when and why to take it...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.